ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

HLS HLS Therapeutics Inc

3.94
-0.20 (-4.83%)
May 17 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Low
3.34

52 Week Range

High
7.12

Share Name Share Symbol Market Stock Type
HLS Therapeutics Inc HLS Toronto Common Stock
  Price Change Price Change % Share Price Last Trade
-0.20 -4.83% 3.94 15:10:13
Open Price Low Price High Price Close Price Previous Close
3.95 3.94 3.96 3.94 4.14
Trades Shares Traded Average Volume 52 Week Range
5 411 - 3.34 - 7.12
Last Trade Type Quantity Price Currency
14:11:26 100 $ 3.94 CAD

HLS Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
126M 31.98M - 63.61M -27.53M -0.86 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

HLS Therapeutics News

Date Time Source News Article
5/09/202405:30PR Newswire (Canada)HLS Therapeutics Announces Q1 2024 Financial Results
4/25/202407:50PR Newswire (Canada)HLS Therapeutics to Host Q1 Fiscal 2024 Financial Results..
4/09/202405:30PR Newswire (Canada)HLS Therapeutics to Present at the 2024 Bloom Burton & Co...
4/08/202405:30PR Newswire (Canada)New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl)..
3/14/202405:30PR Newswire (Canada)HLS Therapeutics Announces Fiscal 2023 Financial Results
2/29/202405:30PR Newswire (Canada)HLS Therapeutics to Host Q4 and Fiscal 2023 Financial..
2/06/202405:30PR Newswire (Canada)HLS Announces that Vascepa® is now reimbursed by British..
12/18/202305:30PR Newswire (Canada)HLS Therapeutics Announces CFO Departure
11/14/202316:12PR Newswire (Canada)New REDUCE-IT® Analyses Show Vascepa® (Icosapent Ethyl)..
11/09/202305:30PR Newswire (Canada)HLS Therapeutics Announces Q3 Fiscal 2023 Financial Results..
10/26/202305:30PR Newswire (Canada)HLS Therapeutics to Host Q3 Fiscal 2023 Financial Results..
9/06/202307:30PR Newswire (Canada)HLS Therapeutics to Present at H.C. Wainwright's 25th Annual..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No HLS Message Board. Create One! See More Posts on HLS Message Board See More Message Board Posts

Historical HLS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.214.223.773.974,867-0.27-6.41%
1 Month4.954.953.774.413,405-1.01-20.40%
3 Months3.985.483.524.1310,699-0.04-1.01%
6 Months3.665.483.343.959,7650.287.65%
1 Year4.507.123.344.9017,417-0.56-12.44%
3 Years17.5020.523.3410.1619,256-13.56-77.49%
5 Years16.2025.913.3414.8730,979-12.26-75.68%

HLS Therapeutics Description

HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets.